The Abbott RealTime HIV-1 assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for the quantitation of Human Immunodeficiency Virus type 1 (HIV-1) on the automated m2000 System in human plasma from HIV-1 infected individuals over the range of 40 to 10,000,000 copies/mL. The Abbott RealTime HIV-1 assay is intended for use in conjunction with clinical presentation and other laboratory markers for disease prognosis and for use as an aid in assessing viral response to antiretroviral treatment as measured by changes in plasma HIV-1 RNA levels.
HIV-1 diversity can be attributed to:
- Error-prone reverse transcriptase enzyme
- Recombination of subtypes
- Cross-species transmission
Accurate quantification is dependent upon a combination of:
- Primer design
- Probe design
- Cycling conditions
The Abbott RealTime HIV-1 assay is designed to detect and quantify all HIV-1 Group M subtypes A–H, Group O, and Group N and provide sensitivity, specificity, and dynamic range to meet your laboratory needs.
This assay is not intended to be used as a donor screening test for HIV-1 or as a diagnostic test to confirm the presence of HIV-1 infection.